<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26559836</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>The C Terminus of the Core &#x3b2;-Ladder Domain in Japanese Encephalitis Virus Nonstructural Protein 1 Is Flexible for Accommodation of Heterologous Epitope Fusion.</ArticleTitle><Pagination><StartPage>1178</StartPage><EndPage>1189</EndPage><MedlinePgn>1178-89</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.02057-15</ELocationID><Abstract><AbstractText Label="UNLABELLED">NS1 is the only nonstructural protein that enters the lumen of the endoplasmic reticulum (ER), where NS1 is glycosylated, forms a dimer, and is subsequently secreted during flavivirus replication as dimers or hexamers, which appear to be highly immunogenic to the infected host, as protective immunity can be elicited against homologous flavivirus infections. Here, by using a trans-complementation assay, we identified the C-terminal end of NS1 derived from Japanese encephalitis virus (JEV), which was more flexible than other regions in terms of housing foreign epitopes without a significant impact on virus replication. This mapped flexible region is located in the conserved tip of the core &#x3b2;-ladder domain of the multimeric NS1 structure and is also known to contain certain linear epitopes, readily triggering specific antibody responses from the host. Despite becoming attenuated, recombinant JEV with insertion of a neutralizing epitope derived from enterovirus 71 (EV71) into the C-terminal end of NS1 not only could be normally released from infected cells, but also induced dual protective immunity for the host to counteract lethal challenge with either JEV or EV71 in neonatal mice. These results indicated that the secreted multimeric NS1 of flaviviruses may serve as a natural protein carrier to render epitopes of interest more immunogenic in the C terminus of the core &#x3b2;-ladder domain.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">The positive-sense RNA genomes of mosquito-borne flaviviruses appear to be flexible in terms of accommodating extra insertions of short heterologous antigens into their virus genes. Here, we illustrate that the newly identified C terminus of the core &#x3b2;-ladder domain in NS1 could be readily inserted into entities such as EV71 epitopes, and the resulting NS1-epitope fusion proteins appeared to maintain normal virus replication, secretion ability, and multimeric formation from infected cells. Nonetheless, such an insertion attenuated the recombinant JEV in mice, despite having retained the brain replication ability observed in wild-type JEV. Mother dams immunized with recombinant JEV expressing EV71 epitope-NS1 fused proteins elicited neutralizing antibodies that protected the newborn mice against lethal EV71 challenge. Together, our results implied a potential application of JEV NS1 as a viral carrier protein to express a heterologous epitope to stimulate dual/multiple protective immunity concurrently against several pathogens.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016, American Society for Microbiology. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yen</LastName><ForeName>Li-Chen</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Jia-Teh</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hwei-Jen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>Wei-Yuan</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chun-Wei</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yi-Ling</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Ching-Len</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan, Republic of China National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan, Republic of China chinglen@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C100315">NS1 protein, Flavivirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014614">Vaccines, Synthetic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004664" MajorTopicYN="N">Encephalitis Virus, Japanese</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004672" MajorTopicYN="N">Encephalitis, Japanese</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014614" MajorTopicYN="N">Vaccines, Synthetic</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26559836</ArticleId><ArticleId IdType="pmc">PMC4719612</ArticleId><ArticleId IdType="doi">10.1128/JVI.02057-15</ArticleId><ArticleId IdType="pii">JVI.02057-15</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murray CL, Jones CT, Rice CM. 2008. Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat Rev Microbiol 6:699&#x2013;708. doi:10.1038/nrmicro1928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1928</ArticleId><ArticleId IdType="pmc">PMC2764292</ArticleId><ArticleId IdType="pubmed">18587411</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler DJ, Kuno G, Markoff L. 2007. Flaviviruses, p 1153&#x2013;1252. In Knipe DM, Howley PM (ed), Fields virology, 5th ed, vol 1 Lippincott Williams &amp; Wilkins, Philadelphia, PA.</Citation></Reference><Reference><Citation>Muller DA, Young PR. 2013. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res 98:192&#x2013;208. doi:10.1016/j.antiviral.2013.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.03.008</ArticleId><ArticleId IdType="pubmed">23523765</ArticleId></ArticleIdList></Reference><Reference><Citation>Edeling MA, Diamond MS, Fremont DH. 2014. Structural basis of Flavivirus NS1 assembly and antibody recognition. Proc Natl Acad Sci U S A 111:4285&#x2013;4290. doi:10.1073/pnas.1322036111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1322036111</ArticleId><ArticleId IdType="pmc">PMC3964132</ArticleId><ArticleId IdType="pubmed">24594604</ArticleId></ArticleIdList></Reference><Reference><Citation>Akey DL, Brown WC, Dutta S, Konwerski J, Jose J, Jurkiw TJ, DelProposto J, Ogata CM, Skiniotis G, Kuhn RJ, Smith JL. 2014. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343:881&#x2013;885. doi:10.1126/science.1247749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1247749</ArticleId><ArticleId IdType="pmc">PMC4263348</ArticleId><ArticleId IdType="pubmed">24505133</ArticleId></ArticleIdList></Reference><Reference><Citation>Akey DL, Brown WC, Jose J, Kuhn RJ, Smith JL. 2015. Structure-guided insights on the role of NS1 in flavivirus infection. Bioessays 37:489&#x2013;494. doi:10.1002/bies.201400182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201400182</ArticleId><ArticleId IdType="pmc">PMC4409125</ArticleId><ArticleId IdType="pubmed">25761098</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung KM, Nybakken GE, Thompson BS, Engle MJ, Marri A, Fremont DH, Diamond MS. 2006. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J Virol 80:1340&#x2013;1351. doi:10.1128/JVI.80.3.1340-1351.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.3.1340-1351.2006</ArticleId><ArticleId IdType="pmc">PMC1346945</ArticleId><ArticleId IdType="pubmed">16415011</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HJ, Lin CF, Lei HY, Liu HS, Yeh TM, Luo YH, Lin YS. 2009. Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies. Exp Biol Med 234:63&#x2013;73. doi:10.3181/0805-RM-147.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0805-RM-147</ArticleId><ArticleId IdType="pubmed">18997103</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua RH, Liu LK, Chen ZS, Li YN, Bu ZG. 2013. Comprehensive mapping antigenic epitopes of NS1 protein of Japanese encephalitis virus with monoclonal antibodies. PLoS One 8:e67553. doi:10.1371/journal.pone.0067553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067553</ArticleId><ArticleId IdType="pmc">PMC3688998</ArticleId><ArticleId IdType="pubmed">23825668</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaldo MC, Sequeira PC, Galler R. 2014. The yellow fever 17D virus as a platform for new live attenuated vaccines. Hum Vaccin Immunother 10:1256&#x2013;1265. doi:10.4161/hv.28117.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.28117</ArticleId><ArticleId IdType="pmc">PMC4896586</ArticleId><ArticleId IdType="pubmed">24553128</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogueira RT, Nogueira AR, Pereira MC, Rodrigues MM, Neves PC, Galler R, Bonaldo MC. 2013. Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi. PLoS One 8:e59347. doi:10.1371/journal.pone.0059347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0059347</ArticleId><ArticleId IdType="pmc">PMC3601986</ArticleId><ArticleId IdType="pubmed">23527169</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao D, Barba-Spaeth G, Rai U, Nussenzweig V, Rice CM, Nussenzweig RS. 2005. Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model. J Exp Med 201:201&#x2013;209. doi:10.1084/jem.20041526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20041526</ArticleId><ArticleId IdType="pmc">PMC2212788</ArticleId><ArticleId IdType="pubmed">15657290</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllister A, Arbetman AE, Mandl S, Pena-Rossi C, Andino R. 2000. Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases. J Virol 74:9197&#x2013;9205. doi:10.1128/JVI.74.19.9197-9205.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.19.9197-9205.2000</ArticleId><ArticleId IdType="pmc">PMC102118</ArticleId><ArticleId IdType="pubmed">10982366</ArticleId></ArticleIdList></Reference><Reference><Citation>Barba-Spaeth G, Longman RS, Albert ML, Rice CM. 2005. Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med 202:1179&#x2013;1184. doi:10.1084/jem.20051352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20051352</ArticleId><ArticleId IdType="pmc">PMC2213233</ArticleId><ArticleId IdType="pubmed">16260489</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaldo MC, Garratt RC, Marchevsky RS, Coutinho ES, Jabor AV, Almeida LF, Yamamura AM, Duarte AS, Oliveira PJ, Lizeu JO, Camacho LA, Freire MS, Galler R. 2005. Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface. J Virol 79:8602&#x2013;8613. doi:10.1128/JVI.79.13.8602-8613.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.13.8602-8613.2005</ArticleId><ArticleId IdType="pmc">PMC1143750</ArticleId><ArticleId IdType="pubmed">15956601</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaldo MC, Garratt RC, Freire MS, Galler R. 2006. Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein. Cell Biochem Biophys 44:313&#x2013;324. doi:10.1385/CBB:44:3:313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/CBB:44:3:313</ArticleId><ArticleId IdType="pubmed">16679518</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaldo MC, Garratt RC, Caufour PS, Freire MS, Rodrigues MM, Nussenzweig RS, Galler R. 2002. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus. J Mol Biol 315:873&#x2013;885. doi:10.1006/jmbi.2001.5258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.2001.5258</ArticleId><ArticleId IdType="pubmed">11812154</ArticleId></ArticleIdList></Reference><Reference><Citation>Rumyantsev AA, Zhang ZX, Gao QS, Moretti N, Brown N, Kleanthous H, Delagrave S, Guirakhoo F, Collett MS, Pugachev KV. 2010. Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus. Virology 396:329&#x2013;338. doi:10.1016/j.virol.2009.10.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.10.033</ArticleId><ArticleId IdType="pubmed">19913267</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajima S, Takasaki T, Kurane I. 2008. Characterization of Asn130-to-Ala mutant of dengue type 1 virus NS1 protein. Virus Genes 36:323&#x2013;329. doi:10.1007/s11262-008-0211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-008-0211-7</ArticleId><ArticleId IdType="pubmed">18288598</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DG, Alonso S, Phoon MC, Ramachandran NP, Chow VT, Poh CL. 2007. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res 125:61&#x2013;68. doi:10.1016/j.virusres.2006.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2006.12.005</ArticleId><ArticleId IdType="pubmed">17222936</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Chou AH, Lien SP, Lin HY, Liu SJ, Chang JY, Guo MS, Chow YH, Yang WS, Chang KH, Sia C, Chong P. 2011. Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Vaccine 29:4362&#x2013;4372. doi:10.1016/j.vaccine.2011.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.04.010</ArticleId><ArticleId IdType="pubmed">21501643</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao CL, Lin YL, Wang JJ, Huang YL, Yeh CT, Ma SH, Chen LK. 1997. Effect of enforced expression of human bcl-2 on Japanese encephalitis virus-induced apoptosis in cultured cells. J Virol 71:5963&#x2013;5971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191852</ArticleId><ArticleId IdType="pubmed">9223486</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen LC, Lin YL, Sung HH, Liao JT, Tsao CH, Su CM, Lin CK, Liao CL. 2013. Neurovirulent flavivirus can be attenuated in mice by incorporation of neuron-specific microRNA recognition elements into viral genome. Vaccine 31:5915&#x2013;5922. doi:10.1016/j.vaccine.2011.09.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.09.102</ArticleId><ArticleId IdType="pubmed">22008823</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang JJ, Liao CL, Liao JT, Lee YL, Lin YL. 2009. A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability. Vaccine 27:2746&#x2013;2754. doi:10.1016/j.vaccine.2009.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.03.007</ArticleId><ArticleId IdType="pubmed">19366580</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Liao CL, Yeh CT, Chang CH, Huang YL, Huang YY, Jan JT, Chin C, Chen LK. 1996. A highly attenuated strain of Japanese encephalitis virus induces a protective immune response in mice. Virus Res 44:45&#x2013;56. doi:10.1016/0168-1702(96)01343-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(96)01343-3</ArticleId><ArticleId IdType="pubmed">8873412</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LK, Lin YL, Liao CL, Lin CG, Huang YL, Yeh CT, Lai SC, Jan JT, Chin C. 1996. Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro. Virology 223:79&#x2013;88. doi:10.1006/viro.1996.0457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1996.0457</ArticleId><ArticleId IdType="pubmed">8806542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2004. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 78:7916&#x2013;7924. doi:10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Falgout B, Markoff L. 1995. Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum. J Virol 69:7232&#x2013;7243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189645</ArticleId><ArticleId IdType="pubmed">7474145</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie JS, Gubler DJ, Petersen LR. 2004. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10:S98&#x2013;S109. doi:10.1038/nm1144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1144</ArticleId><ArticleId IdType="pubmed">15577938</ArticleId></ArticleIdList></Reference><Reference><Citation>Firth AE, Atkins JF. 2009. A conserved predicted pseudoknot in the NS2A-encoding sequence of West Nile and Japanese encephalitis flaviviruses suggests NS1&#x2032; may derive from ribosomal frameshifting. Virol J 6:14. doi:10.1186/1743-422X-6-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-14</ArticleId><ArticleId IdType="pmc">PMC2657137</ArticleId><ArticleId IdType="pubmed">19196463</ArticleId></ArticleIdList></Reference><Reference><Citation>Melian EB, Hinzman E, Nagasaki T, Firth AE, Wills NM, Nouwens AS, Blitvich BJ, Leung J, Funk A, Atkins JF, Hall R, Khromykh AA. 2010. NS1&#x2032; of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. J Virol 84:1641&#x2013;1647. doi:10.1128/JVI.01979-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01979-09</ArticleId><ArticleId IdType="pmc">PMC2812330</ArticleId><ArticleId IdType="pubmed">19906906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Yu Y, Deubel V. 2012. Japanese encephalitis virus NS1&#x2032; protein depends on pseudoknot secondary structure and is cleaved by caspase during virus infection and cell apoptosis. Microbes Infect 14:930&#x2013;940. doi:10.1016/j.micinf.2012.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2012.03.007</ArticleId><ArticleId IdType="pubmed">22504173</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz FX, Stiasny K. 2012. Flaviviruses and flavivirus vaccines. Vaccine 30:4301&#x2013;4306. doi:10.1016/j.vaccine.2011.09.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.09.114</ArticleId><ArticleId IdType="pubmed">22682286</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna VD, Rangappa M, Satchidanandam V. 2009. Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells. J Virol 83:4766&#x2013;4777. doi:10.1128/JVI.01850-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01850-08</ArticleId><ArticleId IdType="pmc">PMC2682061</ArticleId><ArticleId IdType="pubmed">19264772</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>